Showing results (101-110 of 344) with videos related to

Sort By:
Pageof 35
The American Journal of Gastroenterology|October 3, 2002
Risk factors for focal nodular hyperplasia of the liver: an Italian case-control studyAstrid Scalori, Alessandra Tavani, Silvano Gallus, et al.
Tumori|April 16, 2009
Estimates of the incidence and prevalence of hepatocellular carcinoma in Italy in 2002 and projections for the years 2007 and 2012Cristina Bosetti, Cosetta Bianchi, Eva Negri, et al.
Hepatitis Monthly|August 11, 2012
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft ReinfectionAlessio Aghemo, Sherrie Bhoori, Stella De Nicola, et al.
Kidney & Blood Pressure Research|February 22, 2014
Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature reviewFabrizio Fabrizi, Alessio Aghemo, G Battista Fogazzi, et al.
Hepatology (Baltimore, Md.)|January 12, 2024
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosisArmando Tripodi, Massimo Primignani, Roberta D'Ambrosio, et al.
Blood|January 25, 2002
Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapyElena Santagostino, Maria Grazia Rumi, Monica Rivi, et al.
Plos One|March 25, 2014
High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis deltaRaffaella Romeo, Barbara Foglieni, Giovanni Casazza, et al.
Hepatology Communications|October 6, 2018
Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case ReportGiovanni Covini, Elena Bredi, Salvatore Badalamenti, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudinePietro Lampertico, Mauro Viganò, Elena Manenti, et al.
Gastroenterology|November 7, 2007
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patientsPietro Lampertico, Mauro Viganò, Elena Manenti, et al.
Pageof 35